Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fujifilm Diosynth Biotechnologies
Pharma
PD-1 bispecifics, Enhertu, Regeneron-Hansoh—Fierce Pharma Asia
The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal.
Angus Liu
Jun 6, 2025 7:15am
Fujfilm, Coherus among slew of recent biopharma rebrands
Jun 5, 2025 11:04am
Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia
Apr 25, 2025 8:45am
Regeneron taps Fujifilm Diosynth for $3B production agreement
Apr 22, 2025 10:03am
Takeda, Enhertu, East Asian American execs—Fierce Pharma Asia
Jan 31, 2025 8:53am
Fujifilm Diosynth CEO marks 2025 as era of expansion execution
Jan 24, 2025 12:12pm
